Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - STERICYCLE INC | bo8k1210.htm |
EX 99.1
FOR FURTHER INFORMATION CONTACT:
FOR IMMEDIATE RELEASE
Frank ten Brink 847-607-2012
Conference call to be held February 3, 2011 at 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through March 3rd by dialing 800-642-1687, access code 34569946. To hear a live simulcast of the call over the internet on www.earnings.com, or to access an audio archive of the call, go to the Investors page on Stericycle’s website at www.stericycle.com.
STERICYCLE, INC. REPORTS RESULTS
FOR FOURTH QUARTER 2010 AND FULL YEAR
Lake Forest, Illinois, February 3, 2011—Stericycle, Inc. (NASDAQ:SRCL), today reported financial results for the fourth quarter of 2010.
Revenues for the quarter ended December 31, 2010 were $393.5 million, up 25.5% from $313.5 million from the same quarter last year. Acquisitions less than 12 months old contributed approximately $32.5 million to the growth in revenues. Impact from unfavorable foreign exchange in the quarter was $1.0 million. Gross profit was $182.5 million, up 24.0% from $147.1 million in the fourth quarter last year. Gross profit as a percent of revenue was 46.4% compared with 46.9% in the fourth quarter of 2009.
Net income attributable to Stericycle for the fourth quarter of 2010 was $50.0 million or $0.57 per diluted share compared with $44.6 million or $0.52 per diluted share for the fourth quarter of 2009. GAAP net income attributable to Stericycle for the fourth quarter of 2010 reflected various adjustments which, taken together, resulted in non-GAAP earnings per diluted share of $0.69 (see table below). This was a 25.1% increase from our non-GAAP earnings per share of $0.55 in the fourth quarter of 2009.
FULL YEAR RESULTS
For the year ending December 31, 2010, revenues were $1.44 billion, up 22.2% from $1.18 billion in the same period last year. Impact from favorable foreign exchange compared with the same period last year was $2.5 million. Gross profit was $667.4 million, up 20.8% from $552.4 million in the same period last year. Gross profit as a percent of revenue was 46.4% compared with 46.9% in 2009. GAAP earnings per diluted share increased 18.0% to $2.39 from $2.03 per diluted share in the same period last year. Non-GAAP earnings per diluted share, when adjusted for various adjustments, increased to $2.52 from $2.09, or 20.3% (see table below):
![[ex991210002.gif]](ex991210002.gif)
* In accordance with U.S. generally accepted accounting principles (GAAP), reported earnings per share include the after-tax impact of the items identified in this table. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance. This table and the Company’s internal use of non-GAAP earnings per share are not intended to imply, and should not be interpreted as implying, that non-GAAP earnings per share is a better measure of performance than GAAP earnings per share.
Cash flow from operations was $325.7 million for the full year of 2010, which includes $23 million of cash to be used for recalled product reimbursement.
For more information about Stericycle, please visit our website at www.stericycle.com.
Safe Harbor Statement: Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.
STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
In thousands, except share and per share data | |||||
|
| December 31, | |||
|
| 2010 |
|
| 2009 |
|
| (Unaudited) |
|
| (Audited) |
ASSETS |
|
|
|
|
|
Current Assets: |
|
|
|
|
|
Cash and cash equivalents * | $ | 77,053 |
| $ | 15,767 |
Short-term investments |
| 18,471 |
|
| 1,131 |
Accounts receivable, less allowance for doubtful accounts of $10,845 in 2010 and $8,709 in 2009 |
| 215,420 |
|
| 179,770 |
Deferred income taxes |
| 15,822 |
|
| 14,087 |
Prepaid expenses |
| 16,038 |
|
| 12,421 |
Other current assets |
| 24,882 |
|
| 23,364 |
Total Current Assets |
| 367,686 |
|
| 246,540 |
Property, Plant and Equipment, net |
| 267,971 |
|
| 246,154 |
Other Assets: |
|
|
|
|
|
Goodwill |
| 1,595,764 |
|
| 1,394,091 |
Intangible assets, less accumulated amortization of $28,394 in 2010 and $18,546 in 2009 |
| 375,174 |
|
| 269,454 |
Other |
| 35,918 |
|
| 26,564 |
Total Other Assets |
| 2,006,856 |
|
| 1,690,109 |
Total Assets | $ | 2,642,513 |
| $ | 2,182,803 |
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Current portion of long-term debt | $ | 88,899 |
| $ | 78,026 |
Accounts payable |
| 54,777 |
|
| 47,608 |
Accrued liabilities |
| 149,355 |
|
| 92,226 |
Deferred revenues |
| 14,455 |
|
| 14,954 |
Total Current Liabilities |
| 307,486 |
|
| 232,814 |
Long-term debt, net of current portion |
| 1,014,222 |
|
| 910,825 |
Deferred income taxes |
| 224,399 |
|
| 171,744 |
Other liabilities |
| 13,315 |
|
| 10,247 |
Shareholders' Equity: |
|
|
|
|
|
Common stock (par value $.01 per share, 120,000,000
shares authorized, 85,242,387 issued and outstanding
in 2010, 84,715,005 issued and outstanding in 2009) |
| 852 |
|
| 847 |
Additional paid-in capital |
| 46,945 |
|
| 47,522 |
Accumulated other comprehensive loss |
| (14,128) |
|
| (12,292) |
Retained earnings |
| 1,017,497 |
|
| 809,618 |
Total Stericycle, Inc. Shareholders’ Equity |
| 1,051,166 |
|
| 845,695 |
Noncontrolling interest |
| 31,925 |
|
| 11,478 |
Total Shareholders' Equity |
| 1,083,091 |
|
| 857,173 |
Total Liabilities and Shareholders' Equity | $ | 2,642,513 |
| $ | 2,182,803 |
* In 2010 Cash and Cash equivalents includes $23 million to be used for recalled product reimbursement, offset by an equivalent amount in accrued liabilities. |
STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
In thousands, except share and per share data | |||||||||||
| Three Months Ended December 31, |
| Years Ended December 31, | ||||||||
| 2010 |
| 2009 |
| 2010 |
| 2009 | ||||
| (Unaudited) |
| (Unaudited) |
| (Audited) | ||||||
| $ | % of Rev |
| $ | % of Rev |
| $ | % of Rev |
| $ | % of Rev |
Revenues | 393,489 | 100.0 |
| 313,542 | 100.0 |
| 1,439,388 | 100.0 |
| 1,177,736 | 100.0 |
Cost of revenues | 210,833 | 53.6 |
| 165,696 | 52.8 |
| 770,441 | 53.5 |
| 624,636 | 53.0 |
Restructuring costs | 181 | 0.0 |
| 704 | 0.2 |
| 1,520 | 0.1 |
| 704 | 0.1 |
Gross profit | 182,475 | 46.4 |
| 147,142 | 46.9 |
| 667,427 | 46.4 |
| 552,396 | 46.9 |
Selling, general and administrative expenses | 72,419 | 18.4 |
| 60,206 | 19.2 |
| 268,401 | 18.6 |
| 222,483 | 18.9 |
Amortization | 3,267 | 0.8 |
| 1,570 | 0.5 |
| 9,919 | 0.7 |
| 5,390 | 0.5 |
Total SG&A expense and amortization | 75,686 | 19.2 |
| 616776 | 19.7 |
| 278,320 | 19.3 |
| 227,873 | 19.3 |
Income from operations before acquisition, integration, and other expenses | 106,789 | 27.1 |
| 85,366 | 27.2 |
| 389,107 | 27.0 |
| 324,523 | 27.6 |
Transactional expenses related to acquisitions | 6,272 | 1.6 |
| 1,915 | 0.6 |
| 9,519 | 0.7 |
| 7,333 | 0.6 |
Restructuring costs and plant closure expense | 5,744 | 1.5 |
| 905 | 0.3 |
| 6,851 | 0.5 |
| 905 | 0.1 |
Litigation settlement | -- | 0.0 |
| -- | 0.0 |
| 897 | 0.1 |
| -- | 0.0 |
Gain on sale of assets | -- | 0.0 |
| -- | 0.0 |
| (2,955) | -0.2 |
| -- | 0.0 |
Acquisition integration expenses | 859 | 0.2 |
| 630 | 0.2 |
| 4,112 | 0.3 |
| 1,096 | 0.1 |
Income from operations | 93,914 | 23.9 |
| 81,916 | 26.1 |
| 370,683 | 25.8 |
| 315,189 | 26.8 |
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
Interest income | 72 | 0.0 |
| 42 | 0.0 |
| 266 | 0.0 |
| 201 | 0.0 |
Interest expense | (10,739) | -2.7 |
| (8,884) | -2.8 |
| (37,081) | -2.6 |
| (34,333) | -2.9 |
Other income (expense), net | (453) | -0.1 |
| (1,105) | -0.4 |
| (2,015) | -0.1 |
| (3,369) | -0.3 |
Total other income (expense) | (11,120) | -2.8 |
| (9,947) | -3.2 |
| (38,830) | -2.7 |
| (37,501) | -3.2 |
Income before income taxes | 82,794 | 21.0 |
| 71,969 | 23.0 |
| 331,853 | 23.1 |
| 277,688 | 23.6 |
Income tax expense | 32,037 | 8.1 |
| 26,811 | 8.6 |
| 121,396 | 8.4 |
| 101,299 | 8.6 |
Net income | 50,757 | 12.9 |
| 45,158 | 14.4 |
| 210,457 | 14.6 |
| 176,389 | 15.0 |
Net income attributable to noncontrolling interests | 777 | 0.2 |
| 550 | 0.2 |
| 2,578 | 0.2 |
| 698 | 0.1 |
Net income attributable to Stericycle, Inc. | 49,980 | 12.7 |
| 44,608 | 14.2 |
| 207,879 | 14.4 |
| 175,691 | 14.9 |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share-diluted | 0.57 |
|
| 0.52 |
|
| 2.39 |
|
| 2.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding-diluted | 87,279,853 |
|
| 86,353,095 |
|
| 86,962,651 |
|
| 86,744,003 |
|
STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
In thousands | |||||
|
| For the Years Ended December 31, | |||
|
| 2010 |
|
| 2009 |
|
| (Unaudited) |
|
| (Audited) |
OPERATING ACTIVITIES: |
|
|
|
|
|
Net income | $ | 210,457 |
| $ | 176,389 |
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
Gain on sale of assets |
| (2,955) |
|
| -- |
Stock compensation expense |
| 18,564 |
|
| 14,638 |
Excess tax benefit of stock options exercised |
| (24,687) |
|
| (10,905) |
Depreciation |
| 43,966 |
|
| 34,600 |
Amortization |
| 9,919 |
|
| 5,390 |
Deferred income taxes |
| 27,261 |
|
| 22,253 |
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: |
|
|
|
|
|
Accounts receivable |
| (20,791) |
|
| 12,567 |
Accounts payable |
| (165) |
|
| 2,420 |
Accrued liabilities |
| 57,509 |
|
| 21,464 |
Deferred revenues |
| (878) |
|
| 89 |
Other assets |
| 7,470 |
|
| (1,659) |
Net cash provided by operating activities |
| 325,670 |
|
| 277,246 |
|
|
|
|
|
|
INVESTING ACTIVITIES: |
|
|
|
|
|
Payments for acquisitions and international investments, net of cash acquired |
| (190,430) |
|
| (311,891) |
Purchases of short-term investments |
| (16,955) |
|
| 385 |
Proceeds from sale of assets |
| 8,000 |
|
| 1,227 |
Capital expenditures |
| (48,320) |
|
| (39,910) |
Net cash used in investing activities |
| (247,705) |
|
| (350,189) |
|
|
|
|
|
|
FINANCING ACTIVITIES: |
|
|
|
|
|
Repayment of long-term debt |
| (42,377) |
|
| (19,023) |
Net payments on senior credit facility |
| (342,796) |
|
| (59,605) |
Proceeds from term loan |
| 400,000 |
|
| 215,000 |
Payments of deferred financing costs |
| (5,757) |
|
| (3,635) |
Payments on capital lease obligations |
| (2,894) |
|
| (1,106) |
Purchase / cancellation of treasury stock |
| (94,335) |
|
| (75,686) |
Proceeds from other issuance of common stock |
| 49,907 |
|
| 14,922 |
Excess tax benefit of stock options exercised |
| 24,687 |
|
| 10,905 |
Net cash (used in)/ provided by financing activities |
| (13,565) |
|
| 81,772 |
Effect of exchange rate changes on cash |
| (3,114) |
|
| (2,157) |
Net increase in cash and cash equivalents |
| 61,286 |
|
| 6,672 |
Cash and cash equivalents at beginning of period |
| 15,767 |
|
| 9,095 |
Cash and cash equivalents at end of period | $ | 77,053 |
| $ | 15,767 |
|
|
|
|
|
|
NON-CASH ACTIVITIES: |
|
|
|
|
|
Net issuance of notes payable for certain acquisitions | $ | 77,760 |
| $ | 38,090 |